Drugs / Ferumoxytol intravenous
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02499354 Comparator | Aug 2014 → Sep 2021 | iron deficiency anemia, restless legs syndrome | Auerbach Hematology Oncology Associates P C | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ferumoxytol intravenous | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02499354 ↗ |
| Route | Intravenous | “Ferumoxytol intravenous (IV) 1020 mg” NCT02499354 ↗ |